There are emerging data regarding the genomic profiles of MPM and the ways in which these correlate with histology and OS. However, none of this information is yet applicable to clinical care.
Risk Assessment Models
The AJCC recently established guidelines that will be used to evaluate published statistical prediction models for the purpose of granting endorsement for clinical use.
1 Although this is a monumental step toward the goal of precision medicine, this work was published only very recently. Therefore, the existing models that have been published or may be in clinical use have not yet been evaluated for this cancer site by the Precision Medicine Core of the AJCC. In the future, the statistical prediction models for this cancer site will be evaluated, and those that meet all AJCC criteria will be endorsed.
Recommendations for Clinical Trial Stratification
In addition to TNM and overall stage, the following parameters are recommended:
• 
